For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue, known as circulating tumor (ct) DNA.
This report mainly covers the Liquid Biopsy Products product type by technology (circulating Tumor Cells (CTCs), circulating tumor DNA (ctDNA), and extracellular vesicles (or exosomes)), by sample type (blood, urine and other bio fluids (Tissue fluids and Saliva based)), while we can also offer any product survey report related to the liquid biopsy products industry chain.
Scope of the Report:
The sample type of Liquid Biopsy Products is Blood Sample, Urine Sample and Other Bio Fluids. The most proportion of sample type is Blood Sample, and the revenue proportion in 2015 is about 92%.
North America is the largest supplier of Liquid Biopsy Products, with a revenue market share nearly 55% in 2015. Europe is the second largest supplier of Liquid Biopsy Products, enjoying revenue market share nearly 24% in 2015.
Growth of the global liquid biopsy market is mainly driven by increasing prevalence of cancer globally. Increasing prevalence of various cancers such as lung cancer, breast cancer and prostate cancer is expected to drive growth of the liquid biopsy test market over the forecast period.
The worldwide market for Liquid Biopsy Products is expected to grow at a CAGR of roughly 27.8% over the next five years, will reach 2710 million US$ in 2024, from 620 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Liquid Biopsy Products in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- RainDanceTechnologies
- Biocartis
- Qiagen
- Guardant Health
- MDxHealth
- Pathway Genomics
- NeoGenomics Laboraories
- Sysmex Inostics
- Cynvenio
- Menarini Silicon Biosystems
- Adaptive Biotechnologies
- Biocept
- Angle plc
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- CTC
- ctDNA
- Exosomes
Market Segment by Applications, can be divided into
- Blood Sample
- Urine Sample
- Other Bio Fluids
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Liquid Biopsy Products product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Liquid Biopsy Products, with price, sales, revenue and global market share of Liquid Biopsy Products in 2017 and 2018.
Chapter 3, the Liquid Biopsy Products competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Liquid Biopsy Products breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Liquid Biopsy Products market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Liquid Biopsy Products sales channel, distributors, customers, research findings and conclusion, appendix and data source.